This week, four Pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More
5 Stocks With Superb Analyst Earnings Revisions — DXYN LMCA WGO PIKE LCI
This week, these five stocks have the best ratings in Analyst Earnings Revisions, one of the eight Fundamental Categories on Portfolio Grader. More
Why Sheer Lululemon Yoga Pants Could Kill LULU Stock
Lululemon is facing more complaints that its yoga pants are too sheer, and LULU stock still is getting battered by investors. More
3 Huge Healthcare Trends Can Fatten Your Portfolio
Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities More
Caesars Wants to Build a NY Casino
Caesars Entertainment, along with many other gaming companies, have shown interest in building casinos in New York. More
Microsoft Stock Meets Resistance – 13 Years’ Worth of It
After the latest MSFT earnings report, Microsoft stock has moved higher in good fashion and awoken bullish spirits that have been asleep for way too long. More
Should I Buy RIG Stock? 3 Pros, 3 Cons
A strong deepwater drilling market and more efficient use of its rigs helped RIG rock its quarterly earnings, sending the company’s stock up 7% on Thursday. More
